Medical-biological research and the economic exploitation of research results, particularly in immunology, endocrinology, hematology, neuropharmacology, virology, and cancer research, as well as the development of new methods for organ and bone marrow transplants; scientific validation, creation, formulation, production, and sale of innovative dietary supplements and cosmetics; marketing and sale of new galenic formulations and approved and registered pharmaceutical products in the field of autoimmune, neurodegenerative, and cardiovascular diseases. The company may acquire and sell licenses and patents. It may participate in other companies in Switzerland and abroad and support organizations of public utility. The company may engage in any commercial, financial, or other activity directly or indirectly related to its purpose, as well as carry out all operations aimed at achieving its social purpose directly or indirectly and participate in any form in other companies with similar purposes.